Samrat Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹66 crore and net profit of ₹0.44 crore for the September 2026 quarter.
Samrat Pharma (BSE: SAMRATPH) closed at ₹223.30 on 20 Nov 2026, down 18.6% over the past year. Its market capitalisation is ₹69 crore.
Incorporated in 1992, Samrat Pharmachem Ltd does manufacturing and selling of chemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.